Five years experience of transrectal high‐intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer

Background:  High‐intensity focused ultrasound (HIFU) is a minimally invasive technique used in achieve coagulation necrosis. We evaluated biochemical disease‐free survival rates, predictors of clinical outcome and morbidity in patients with localized prostate cancer treated with HIFU.

[1]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[2]  A. Partin,et al.  Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease. , 2000, The Journal of urology.

[3]  Guy Vallancien,et al.  High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. , 2003, Journal of endourology.

[4]  W J FRY,et al.  Production of focal destructive lesions in the central nervous system with ultrasound. , 1954, Journal of neurosurgery.

[5]  L. Curiel,et al.  Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. , 2004, Urology.

[6]  Guy Vallancien,et al.  Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. , 2004, The Journal of urology.

[7]  J P Donohue,et al.  High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experience. , 1994, The Journal of urology.

[8]  J. J. de la Rosette,et al.  Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. , 1999, Urology.

[9]  T. Sobue,et al.  [Current status and trends in cancer mortality in Japan]. , 2004, Gan to kagaku ryoho. Cancer & chemotherapy.

[10]  Michael W Kattan,et al.  Cancer control with radical prostatectomy alone in 1,000 consecutive patients. , 2002, The Journal of urology.

[11]  M. Marberger,et al.  Transcutaneous High-Intensity Focused Ultrasound and Irradiation: An Organ-Preserving Treatment of Cancer in a Solitary Testis , 1998, European Urology.

[12]  J M Dubernard,et al.  Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. , 1996, European urology.

[13]  T. Uchida,et al.  Clinical outcome of high-intensity focused ultrasound for treating benign prostatic hyperplasia: preliminary report. , 1998, Urology.

[14]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Marberger,et al.  Effect of high-intensity focused ultrasound on human prostate cancer in vivo. , 1995, Cancer research.

[16]  D. Beyer,et al.  The evolving role of prostate brachytherapy. , 2001, Cancer control : journal of the Moffitt Cancer Center.

[17]  C. Chaussy,et al.  The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection , 2003, Current urology reports.

[18]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[19]  Michael J. Zelefsky,et al.  Comparison of the 5-Year Outcome and Morbidity of Three-Dimensional Conformal Radiotherapy Versus Transperineal Permanent Iodine-125 Implantation for Early-Stage Prostatic Cancer , 1999 .

[20]  James D. Cox,et al.  Consensus statement: Guidelines for PSA following radiation therapy , 1997 .

[21]  Narendra T. Sanghvi,et al.  Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. , 2002, Urology.

[22]  G. Gustafson,et al.  A comprehensive review of prostate cancer brachytherapy: defining an optimal technique. , 1999, International journal of radiation oncology, biology, physics.

[23]  E. B. Butler,et al.  Intensity Modulated Radiation Therapy (IMRT) in the Management of Prostate Cancer , 2004, Cancer investigation.

[24]  Bernhard Walter,et al.  High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. , 2004, Urology.

[25]  Amnon Zisman,et al.  Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. , 2003, The Journal of urology.

[26]  Hiroyuki Fujimoto,et al.  Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association , 2005, International journal of urology : official journal of the Japanese Urological Association.

[27]  J. Lettvin,et al.  Changes produced in the central nervous system by ultrasound. , 1951, Science.

[28]  K. Wallner,et al.  Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[29]  Wen-Zhi Chen,et al.  Preliminary experience using high intensity focused ultrasound for the treatment of patients with advanced stage renal malignancy. , 2003, The Journal of urology.

[30]  G Vallancien,et al.  Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute. , 2003, The Journal of urology.